000 02234nam a22003618i 4500
001 CR9780511526992
003 UkCbUP
005 20200124160226.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 090407s1998||||enk o ||1 0|eng|d
020 _a9780511526992 (ebook)
020 _z9780521473217 (hardback)
020 _z9780521030748 (paperback)
040 _aUkCbUP
_beng
_erda
_cUkCbUP
050 0 0 _aRC271.C5
_bD7778 1998
082 0 0 _a616.99/4061
_221
245 0 0 _aDrug resistance in the treatment of cancer /
_cedited by Herbert M. Pinedo and Giuseppe Giaccone.
264 1 _aCambridge :
_bCambridge University Press,
_c1998.
300 _a1 online resource (xvi, 323 pages) :
_bdigital, PDF file(s).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aCancer, clinical science in practice
500 _aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
520 _aThe development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivalled authority. Chapters cover topics of current clinical concern, including multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support. The authors are among the leading clinicians and investigators in the field. These authoritative volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the applications of biomedical science to the understanding and management of cancer.
650 0 _aDrug resistance in cancer cells.
700 1 _aPinedo, H. M.,
_eeditor.
700 1 _aGiaccone, Giuseppe,
_eeditor.
776 0 8 _iPrint version:
_z9780521473217
830 0 _aCancer, clinical science in practice.
856 4 0 _uhttps://doi.org/10.1017/CBO9780511526992
999 _c517196
_d517194